EHA2021 CML Poster Sessions

 

Posters Sessions

On demand from 11 June 2021, 09:00 AM CET.

eha logo3

 

Chronic myeloid leukemia - Biology & Translational Research

 

  • EP655 (EP655) NEUTROPHIL EXTRACELLULAR TRAPS ARE INCREASED IN CHRONIC MYELOID LEUKEMIA AND ARE DIFFERENTIALLY AFFECTED BY TYROSINE KINASE INHIBITORS. Dr. Alona Telerman, Israel.
  • EP656 (EP656) PROFILES OF NK CELL SUBSETS ARE ASSOCIATED WITH SUCCESSFUL TYROSINE KINASE INHIBITOR DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA AND CHANGE FOLLOWING INTERFERON TREATMENT. Dr. Hao Jiang, China.
  • EP657 (EP657) TNF-MEDIATED CML CELL SURVIVAL RESISTS TKI TREATMENT AND THIS CAN BE TARGETED BY IKK2-INHIBITION. Dr. Marlena Bütow, Germany.
  • EP658 (EP658) AGE-RELATED DNA DAMAGE RESPONSE (DDR) IN HEMATOPOIETIC STEM CELLS FROM CHRONIC MYELOID LEUKAEMIA PATIENTS WHO ATTEMPTED TKI DISCONTINUATION.. Dr. Chiara Manfroni, Italy
  • EP659 (EP659) ASSESSMENT OF LEUKEMIC STEM CELL CD26+ IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH DEEP MOLECULAR RESPONSE. Dr. Raquel Bengio, Argentina.
  • EP660 (EP660) EUTOS EXPERIENCE OF STANDARDISATION OF MOLECULAR MONITORING FOR CML (2016 – 2020). USE OF SECONDARY BCR-ABL1 REFERENCE MATERIALS FOR CONVERSION FACTOR VALIDATION AND ASSESSMENT OF MR4.5 DETECTION. Dr. Helen White, United Kingdom.
  • EP661 (EP661) ANALYSIS OF MRNA AND DNA LEVEL OF ATYPICAL BCR-ABL1 TRANSCRIPTS IN CML PATIENTS OUTLINED AN ELIGIBILITY FOR TKI STOPPING. Dr. Katerina Machova Polakova, Czech Republic.
  • EP662 (EP662) ANALYSIS OF MYELOID MUTATIONS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA AND THEIR ASSOCIATION WITH ADVERSE EVENTS AND RELAPSE AFTER DISCONTINUATION. . Dr. Adrian Segura Diaz, Spain.
  • EP663 (EP663) COMPREHENSIVE IMMUNOPROFILE OF NK CELLS FROM CML PATIENTS IN TFR REVEALS A POSSIBLE ROLE OF MEMORY-LIKE NK CELLS. Dr. Maria Belen Sanchez, Argentina.
  • EP664 (EP664) TARGETING THE LEUKEMIC STEM CELL NICHE BY PI3K INHIBITORS IN CHRONIC MYELOID LEUKEMIA TO OVERCOME LEUKEMIC STEM CELL RESISTANCE. Dr. Yüksel Filik, Austria.
  • EP665 (EP665) RARE MUTATIONS IN BCR-ABL THE KINASE DOMAIN IN CRONIC MYELOID LEUKEMIA PATIENTS. Dr. Austin Kulasekararaj, Argentina.

 

Chronic myeloid leukemia – Clinical

 

  • EP666 (EP666) NEGATIVE PROGNOSTIC IMPACT OF HIGH-RISK ADDITIONAL CYTOGENETIC ABNORMALITIES IN ADDITION TO THE ELTS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA. Dr. Giada Ingoglia, Switzerland.
  • EP667 (EP667) TREATMENT-FREE REMISSION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE FOLLOWING FRONTLINE NILOTINIB: RESULTS FROM JALSG N-STOP216. Prof. Dr. Naoto Takahashi, Japan.
  • EP668 (EP668) TREATMENT-FREE REMISSION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE FOLLOWING FRONTLINE DASATINIB: RESULTS FROM JALSG D-STOP216. Dr. Yosuke Minami, Japan.
  • EP669 (EP669) COMPARISON OF THE SOKAL AND EUTOS LONG-TERM SURVIVAL SCORES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA RECEIVING TYROSINE KINASE INHIBITORS. Dr. Xiaoshuai Zhang, China
  • EP670 (EP670) ASCIMINIB RESPONSES IN PONATINIB-PRETREATED PATIENTS WITH CHRONIC MYELOID LEUKEMIA. Dr. Alejandro Luna, Spain.
  • EP671 (EP671) OUTCOMES BEFORE AND AFTER DOSE REDUCTION IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA RECEIVING BOSUTINIB OR IMATINIB. Dr. Michael Deininger, United States.
  • EP672 (EP672) SECOND-LINE BOSUTINIB FOR PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA : FINAL 10-YEAR RESULTS OF A PHASE 1/2 STUDY. Dr. Carlo Gambacorti-Passerini, Italy.
  • EP673 (EP673) TREATMENT-FREE REMISSION IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH LOW-DOSE TKIS. A FEASIBLE OPTION ALSO IN THE REAL-LIFE SETTING? Dr. Alessandra Iurlo, Italy.
  • EP674 (EP674) COVID-19 IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: DISEASE OUTCOMES AND FIRST VACCINATION DATA IN RUSSIAN FEDERATION. Dr. Ekaterina Chelysheva, Russia.
  • EP675 (EP675) ASSOCIATION OF CREATINE KINASE ELEVATION WITH CLINICAL OUTCOMES IN CHRONIC MYELOID LEUKEMIA. Dr. Aniket Bankar, Canada.
  • EP676 (EP676) FRONTLINE TREATMENT APPROACHES FOR CML IN MYELOID BLAST PHASE: A SINGLE-CENTER EXPERIENCE OVER 2 DECADES. Dr. Kapil Saxena, United States.
  • EP677 (EP677) EFFECT OF COMORBIDITIES ON PATIENT RESPONSES WITH FIRST-LINE DASATINIB VERSUS IMATINIB IN CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE: EXPLORATORY POST HOC ANALYSIS OF DASISION. Dr. Massimo Breccia, Italy.
  • EP678 (EP678) HYDROXYUREA PRE-TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS: MORE HARM THAN GOOD? Dr. Giada Ingoglia, Switzerland.
  • EP679 (EP679) FRENCH REAL–LIFE OBSERVATIONAL STUDY “TOPASE” EVALUATING SAFETY AND EFFICACY OF PONATINIB CONFIRMS INDUCTION OF DEEP MOLECULAR RESPONSES IN 110 RESISTANT OR INTOLERANT CML PATIENTS. Dr. Ali Turhan, France.
  • EP680 (EP680) WITHDRAWAL SYNDROME AFTER TYROSINE KINASE INHIBITORS DISCONTINUATION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA. Dr. Anna Petrova, Russia
  • EP681 (EP681) FIRST INTERIM RESULTS OF THE RUSSIAN PROSPECTIVE STUDY OF REDUCTION AND DISCONTINUATION TREATMENT OF TKI (READIT) IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH DEEP MOLECULAR RESPONSE. Dr. Margarita Gurianova, Russia.
  • EP682 (EP682) A SURVEY OF HEALTHCARE PROFESSIONALS IN THE UNITED KINGDOM TO DESCRIBE CURRENT PATHWAYS AND MANAGEMENT PRACTICES IN CHRONIC MYELOID LEUKAEMIA: THE ADAPT CML SURVEY. Dr. Adam Mead, United Kingdom.
  • EP683 (EP683) TREATMENT ADHERENCE IN CHRONIC MYELOID LEUKEMIA PATIENTS RECEIVING TYROSINE KINASE INHIBITORS. Dr. Benlazar Sidi Mohamed El Amine, Algeria.
  • EP684 (EP684) THE EFFECT OF BODY MASS INDEX ON EFFICACY AND SAFETY OF BOSUTINIB OR IMATINIB IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA. Dr. Tim H Brümmendorf, Germany.

 

Quality of life, palliative care, ethics and health economics.

 

  • EP1172 (EP1172) THE PSYCHOSOCIAL IMPACT OF HAEMATOPOIETIC STEM CELL TRANSPLANTATION ON ADULT PATIENTS WITH LYMPHOMA, LEUKAEMIA OR MYELODYSPLASTIC SYNDROMES – A LITERATURE REVIEW. Dr. Pauline Frank, Switzerland.
  • EP1175 (EP1175) QUANTIFYING PATIENT PREFERENCES FOR TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA: A DISCRETE-CHOICE EXPERIMENT. Dr. Bradley Mason, United Kingdom.
  • EP1185 (EP1185) IMPACT OF THE COVID-19 PANDEMIC ON HEALTH-RELATED QUALITY OF LIFE AND ANXIETY IN PEDIATRIC HEMATOLOGY/ONCOLOGY PATIENTS: A SINGLE EGYPTIAN CENTER EXPERIENCE. Dr. Yasmine El Chazli, Egypt.
  • EP1196 (EP1196) CHRONIC MYELOID LEUKEMIA ACCESS TO TYROSINE KINASE INHIBITORS AND POLYMERASE CHAIN REACTION TESTING IN CENTRAL AND EASTERN EUROPE AND WEST ASIA REGION: A PATIENT ADVOCACY PERSPECTIVE. Dr. Jelena Čugurović, Serbia.

 

  

 

Please donate!

Please donate!

LogIn

EU e-Privacy Directive